FDA 21 CFR Part 11
FDA regulation equating electronic records to paper equivalents
23 NYCRR 500
NY regulation for financial services cybersecurity
Quick Verdict
FDA 21 CFR Part 11 ensures electronic records/signatures trust for life sciences, while 23 NYCRR 500 mandates broad cybersecurity for NY financial firms. Pharma adopts Part 11 for FDA compliance; banks use 500 to avoid DFS fines and protect NPI.
FDA 21 CFR Part 11
21 CFR Part 11 Electronic Records; Electronic Signatures
Key Features
- Establishes electronic records/signatures equivalent to paper/handwritten
- Mandates secure, time-stamped audit trails for changes
- Requires unique, non-repudiable electronic signatures with manifestation
- Differentiates controls for closed vs. open systems
- Enforces validation, access limits, and authority checks
23 NYCRR 500
23 NYCRR Part 500 Cybersecurity Regulation
Key Features
- Annual CEO/CISO dual compliance certification
- 72-hour cybersecurity incident notification to NYDFS
- Phishing-resistant MFA for privileged/remote access
- Risk-based TPSP security policy and contracts
- Annual penetration testing and vulnerability management
Detailed Analysis
A comprehensive look at the specific requirements, scope, and impact of each standard.
FDA 21 CFR Part 11 Details
What It Is
FDA 21 CFR Part 11 is a U.S. regulation establishing criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using electronic systems for predicate-rule records. The risk-based approach narrows scope to relied-upon electronic records, with enforcement discretion for validation, audit trails, retention, and copies per 2003 guidance.
Key Components
- **Subpart BControls for closed (§11.10) and open (§11.30) systems, including validation, audit trails, access limits, checks, signatures manifestation/linking.
- **Subpart CElectronic signature requirements (§§11.50-11.300) for uniqueness, multi-component controls, non-repudiation.
- Core principles: authenticity, integrity, confidentiality, accountability. No fixed control count; focuses on 11+ key controls like training, policies.
- Compliance via self-assessment, FDA inspection; no third-party certification.
Why Organizations Use It
Mandated for life sciences using electronic records; ensures data integrity for inspections, avoids warning letters. Benefits: inspection readiness, quality decisions, efficiency. Builds trust, reduces recalls, supports digital transformation.
Implementation Overview
Risk-based: scope records, classify systems, validate (CSV/IQ/OQ/PQ), implement controls, train, SOPs. Applies to pharma, devices, biotech; phased (6-24+ months). FDA audits via inspections.
23 NYCRR 500 Details
What It Is
23 NYCRR Part 500 is the New York Department of Financial Services (NYDFS) Cybersecurity Regulation, a prescriptive state-level mandate for financial services entities. It establishes minimum risk-based cybersecurity requirements to protect nonpublic information (NPI) and ensure operational integrity, applying to Covered Entities like banks, insurers, and mortgage firms licensed in New York.
Key Components
- 14 core requirements including cybersecurity program, CISO governance, MFA, encryption, TPSP oversight, penetration testing, and 72-hour incident reporting.
- Risk-based approach with annual assessments, dual CEO/CISO certification by April 15, and five-year record retention.
- Enhanced rules for Class A Companies (e.g., >$20M NY revenue, >2,000 employees) like independent audits and EDR.
Why Organizations Use It
- Mandatory compliance avoids multimillion-dollar fines (e.g., Robinhood $30M).
- Reduces cyber risk, improves resilience, and builds stakeholder trust.
- Aligns with enterprise risk management for competitive edge.
Implementation Overview
- Phased roadmap: gap analysis, asset inventory, MFA rollout, TPSP contracts, testing.
- Applies to NY-licensed financial entities; no certification but annual filing and DFS examinations.
Key Differences
| Aspect | FDA 21 CFR Part 11 | 23 NYCRR 500 |
|---|---|---|
| Scope | Electronic records/signatures trustworthiness | Broad cybersecurity program and NPI protection |
| Industry | Life sciences, pharma, medical devices (US) | NY financial services entities (state-specific) |
| Nature | Mandatory FDA regulation with enforcement discretion | Mandatory state regulation with active enforcement |
| Testing | Risk-based system validation (IQ/OQ/PQ) | Annual pen testing, bi-annual vulnerability scans |
| Penalties | Warning letters, product holds, CGMP violations | Multi-million fines, consent orders, license actions |
Scope
Industry
Nature
Testing
Penalties
Frequently Asked Questions
Common questions about FDA 21 CFR Part 11 and 23 NYCRR 500
FDA 21 CFR Part 11 FAQ
23 NYCRR 500 FAQ
You Might also be Interested in These Articles...

CIS Controls v8.1 IG1 Ransomware-Resilience Sprint: A 30-60-90 Day Action Plan (With Evidence Checklist)
Tactical CIS Controls v8.1 IG1 playbook for ransomware resilience. 30-60-90 day sprint with tool-agnostic tasks, ownership & evidence checklists to prove progre

ISO 27701 Standalone Certification in 2025: Debunking Myths and Navigating the New Reality
Debunk myths on ISO 27701 standalone certification post-2025. Clarify viability, accreditation bodies, ISO 27001 audit differences & procurement benefits. Guide

CIS Controls v8.1 for Cloud & Kubernetes: A Practical Implementation Playbook (AWS/Azure/GCP + IaC)
Translate CIS Controls v8.1 to cloud-native: Kubernetes patterns for IAM, logging, vuln mgmt, hardening on AWS, Azure, GCP + IaC. Practical playbook for teams.
Run Maturity Assessments with GRADUM
Transform your compliance journey with our AI-powered assessment platform
Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.
Check out these other Gradum.io Standards Comparison Pages
ISO 22301 vs ISO 56002
Compare ISO 22301 vs ISO 56002: Resilience for disruptions meets innovation frameworks. Discover PDCA synergies, clause alignments & IMS benefits. Boost your strategy now!
CSL (Cyber Security Law of China) vs CCPA
CSL vs CCPA: China's data localization & security mandates vs CA consumer rights to know, delete, opt-out. Expert compliance guide, fines, strategies & pitfalls.
ISO 14001 vs EU AI Act
Compare ISO 14001 vs EU AI Act: Discover key differences in EMS frameworks and AI risk governance. Unlock compliance strategies, lifecycle insights, and integration tips for sustainable innovation today.